RE:ApplauseI spoke to Graeme, and it looks like your question on what the dual strategy is will be clarified soon. Mark is putting together a business plan that (I think) will be published to all of us. From what I inferred the dual strategy will be to pursue preclinical studies in primates while pursuing licensing opporutnities with some assistance from seasoned deal-makers that have recently joined the board and the exec team. Bioasis is trying for a second wind here and we should tamper our expectations. I don't think our exit startegy is less than a year away, and there may be a few financings in between now and then. Good luck to you all!
TB
Technicalbuy.com